Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Recurrent Paranasal Sinus and Nasal Cavity Cancer

Chemotherapy for recurrent head and neck squamous cell cancer has shown promise. Chemotherapy may be indicated where there is recurrence in either distant or local disease after primary surgery or radiation, and when there is residual disease after primary treatment.[1,2] Survival may be improved in those achieving a complete response to chemotherapy.[3] Combined modality therapy with platinum and radiation therapy has been used in trials such as UMCC-8810.[4]

Standard treatment options:

Recommended Related to Cancer

To Learn More About Plasma Cell Neoplasms

For more information from the National Cancer Institute about multiple myeloma and other plasma cell neoplasms, see the following: Multiple Myeloma/Other Plasma Cell Neoplasms Home Page What You Need to Know About™ Multiple Myeloma Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms Targeted Cancer Therapies Understanding Cancer Series: Targeted Therapies (Advances in Targeted Therapies and Targeted Therapies for Multiple Myeloma) Bone Marrow Transplantation a...

Read the To Learn More About Plasma Cell Neoplasms article > >

  1. For maxillary sinus tumors:
    • After surgery, radiation therapy or craniofacial resection with postoperative radiation therapy.
    • After radiation therapy, craniofacial resection if indicated.
    • Chemotherapy should be considered after failure of the above.
  2. For ethmoid sinus tumors:[5,6,7]
    • After limited surgery, craniofacial resection or radiation therapy or both.
    • After radiation therapy, craniofacial resection.
    • Chemotherapy should be considered after failure of the above.
  3. For sphenoid sinus tumors:
    • Treatment is the same as for nasopharyngeal cancers, primarily radiation therapy.
    • Chemotherapy should be considered after failure of the above.
  4. For nasal cavity tumors (squamous cell carcinomas) salvage is possible in approximately 25% of patients:
    • For failure after radiation therapy, craniofacial resection.
    • For failure after surgery, radiation therapy.
    • Chemotherapy should be considered after failure of the above.
  5. For inverting papilloma:
    • Surgical excision.
    • Re-excision for surgery failures.
    • Radical surgery or radiation therapy may eventually be necessary.
  6. For melanomas and sarcomas:
    • Surgical excision if possible.
    • Appropriate chemotherapy geared specifically to cell type. (Refer to the Recurrent Nasopharyngeal Cancer section and the Recurrent Major Salivary Gland Cancer section of the PDQ summaries on Nasopharyngeal Cancer Treatment and Salivary Gland Cancer Treatment, respectively, for more information.)
  7. For midline granuloma:
    • Radiation therapy to nasal cavity and paranasal sinuses.
  8. For nasal vestibule tumors:
    • For radiation therapy failures, surgery.
    • For surgery failures, radiation therapy or a combination of surgery and radiation therapy.
    • Chemotherapy should be considered after failure of the above.

Treatment options under clinical evaluation:

  • For maxillary sinus tumors, ethmoid sinus tumors, nasal cavity tumors, and nasal vestibule tumors, clinical trials using chemotherapy should be considered.[8,9]

Current Clinical Trials

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent paranasal sinus and nasal cavity cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site.

References:

  1. Kies MS, Levitan N, Hong WK: Chemotherapy of head and neck cancer. Otolaryngol Clin North Am 18 (3): 533-41, 1985.
  2. LoRusso P, Tapazoglou E, Kish JA, et al.: Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University. Cancer 62 (1): 1-5, 1988.
  3. Al-Kourainy K, Kish J, Ensley J, et al.: Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59 (2): 233-8, 1987.
  4. Al-Sarraf M, Pajak TF, Marcial VA, et al.: Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer 59 (2): 259-65, 1987.
  5. Kraus DH, Sterman BM, Levine HL, et al.: Factors influencing survival in ethmoid sinus cancer. Arch Otolaryngol Head Neck Surg 118 (4): 367-72, 1992.
  6. Cantù G, Solero CL, Mariani L, et al.: Anterior craniofacial resection for malignant ethmoid tumors--a series of 91 patients. Head Neck 21 (3): 185-91, 1999.
  7. Shah JP: Surgery of the anterior skull base for malignant tumors. Acta Otorhinolaryngol Belg 53 (3): 191-4, 1999.
  8. Brasnu D, Laccourreye O, Bassot V, et al.: Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base. Arch Otolaryngol Head Neck Surg 122 (7): 765-8, 1996.
  9. Licitra L, Locati LD, Cavina R, et al.: Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 14 (3): 367-72, 2003.
1

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article